Home » Topics » Regulatory

Regulatory
RSS

FDA approves Juxtapid for homozygous familial hypercholesterolemia

Dec. 27, 2012

FDA expands approval of Tamiflu

Dec. 24, 2012

FDA approves Biotest's IVIG for primary humoral immunodeficiency

Dec. 21, 2012

GSK's four-strain seasonal influenza vaccine Fluarix Quadrivalent approved for use in U.S.

Dec. 18, 2012

FDA approves GSK's raxibacumab for inhalational anthrax

Dec. 17, 2012

FDA expands indication for Zytiga

Dec. 12, 2012

FDA approves Cometriq, EMA accepts MAA

Nov. 30, 2012

FDA approves Zilver PTX drug-eluting stent for peripheral arterial disease

Nov. 16, 2012

Bristol-Myers Squibb and AstraZeneca gain European approval for dapagliflozin

Nov. 15, 2012

FDA approves Pfizer's Xeljanz for rheumatoid arthritis

Nov. 8, 2012